[1]廖道明,朱 茜.双岐四联活菌片联合蒙脱石散治疗小儿腹泻临床疗效观察[J].医学信息,2019,32(06):159-160,163.[doi:10.3969/j.issn.1006-1959.2019.06.051]
　LIAO Dao-ming,ZHU Qian.Clinical Observation of the Treatment of Diarrhea in Children with Bifidobacterium Tetracycline Tablet Combined with Montmorillonite Powder[J].Journal of Medical Information,2019,32(06):159-160,163.[doi:10.3969/j.issn.1006-1959.2019.06.051]
点击复制

双岐四联活菌片联合蒙脱石散治疗小儿腹泻临床疗效观察()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年06期
页码:
159-160,163
栏目:
药物与临床
出版日期:
2019-03-15

文章信息/Info

Title:
Clinical Observation of the Treatment of Diarrhea in Children with Bifidobacterium Tetracycline Tablet Combined with Montmorillonite Powder
文章编号:
1006-1959（2019）06-0159-03
作者:
廖道明1; 朱 茜2
（江西省瑞金市人民医院小儿科1，五官科2，江西 瑞金 342500）
Author(s):
LIAO Dao-ming1; ZHU Qian2
(Department of Pediatrics1,Department of Facial Organs2,Ruijin People's Hospital,Ruijin 342500,Jiangxi,China)
关键词:
双岐四联活菌片; 蒙脱石散; 小儿腹泻
Keywords:
Bifidobacterium tetracycline tablet; Montmorillonite powder; Diarrhea in children
分类号:
R725.7
DOI:
10.3969/j.issn.1006-1959.2019.06.051
文献标志码:
A
摘要:
目的 探讨双岐四联活菌片联合蒙脱石散治疗小儿腹泻临床疗效。方法 选取2017年1月~2018年1月我院收治的小儿腹泻患儿100例，随机分为观察组和对照组，每组50例。对照组采用蒙脱石散治疗，观察组在对照组基础上加用双岐四联活菌片治疗。比较两组患者的临床疗效、用药前后腹泻积分、小儿营养情况（ALB、HGB、TP）、止泻的平均天数、腹痛持续时间、体温正常时间、呕吐消失时间以及不良反应情况。结果 观察组总有效率为98.00%，高于对照组的78.00%，差异具有统计学意义（P＜0.05）。用药后观察组腹泻积分为（0.25±0.05）分，低于对照组的（1.14±0.11）分，差异具有统计学意义（P＜0.05）；观察组ALB、HGB、TP水平均高于对照组，差异具有统计学意义（P＜0.05）。观察组止泻平均天数、腹痛持续时间、体温正常时间、呕吐消失时间均短于对照组，差异具有统计学意义（P＜0.05）。两组不良反应发生率比较，差异无统计学意义（P＞0.05）。结论 蒙脱石散联合双岐四联活菌片治疗小儿腹泻，临床疗效显著，可加速病情康复，改善营养情况，安全性好。
Abstract:
Objective To investigate the clinical efficacy of Bifidobacterium tetracycline tablet combined with Montmorillonite powder in the treatment of diarrhea in children. Methods A total of 100 children with diarrhea in our hospital from January 2017 to January 2018 were randomly divided into observation group and control group, with 50 cases in each group. The control group was treated with Montmorillonite powder, and the observation group was treated with the Bifidobacterium tetracycline tablet on the basis of the control group. The clinical efficacy, diarrhea score before and after medication, pediatric nutrition (ALB, HGB, TP), average days of diarrhea, duration of abdominal pain, normal temperature of body temperature, time of disappearance of vomiting, and adverse reactions were compared between the two groups. Results The total effective rate of the observation group was 98.00%, which was higher than that of the control group 78.00%,the difference was statistically significant (P<0.05). After treatment, the score of diarrhea in the observation group was (0.25±0.05), which was lower than that in the control group (1.14±0.11),the difference was statistically significant (P<0.05). The ALB, HGB and TP levels in the observation group were higher than those in the control group,the difference was statistically significant (P<0.05). The average days of diarrhea, duration of abdominal pain, normal temperature of body temperature, and disappearance of vomiting were shorter in the observation group than in the control group,the difference was statistically significant (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusion The combination of Montmorillonite powder and Bifidobacterium tetracycline tablet in the treatment of diarrhea in children has a significant clinical effect, which can accelerate the recovery of the disease, improve the nutritional status and safety.

参考文献/References:

[1]成延忠.双歧四联活菌片联合蒙脱石散治疗小儿腹泻的疗效及对患儿免疫功能的影响[J].中国医药指南,2018,16(23):16-17. [2]王永辉.分析双歧三联活菌片联合蒙脱石散治疗小儿腹泻的临床疗效[J].北方药学,2017,14(9):71-72. [3]高才秀.双岐四联活菌片联合蒙脱石散治疗小儿腹泻临床疗效观察[J].临床医药文献电子杂志,2018,5(57):106-107. [4]金巧云.探析双歧三联活菌片联合蒙脱石散治疗小儿腹泻的临床疗效及对患儿免疫功能的影响[J].北方药学,2017,14(9):140-141. [5]李楚辉.双歧四联活菌片联合蒙脱石散治疗小儿腹泻对患儿免疫功能的影响[J].深圳中西医结合杂志,2018,28(8):167-168. [6]李望云,赵文娟,胡勤.双歧四联活菌片联合蒙脱石散治疗小儿腹泻效果及对患儿免疫功能的影响[J].中国中西医结合儿科学,2018,10(2):150-152. [7]顾红英.双歧四联活菌片联合蒙脱石散治疗小儿腹泻的临床疗效及其安全性[J].临床合理用药杂志,2018,11(12):25-26. [8]陈凯鹏,林惠玲,张楠.双歧杆菌乳杆菌四联活菌片联合蒙脱石散治疗小儿腹泻的效果观察[J].中国医药科学,2018,8(8):61-63,69. [9]苏永智,蔡绵碧.双歧三联活菌片联合蒙脱石散治疗儿童抗生素相关性腹泻疗效观察[J].哈尔滨医药,2018,38(2):118-119.

相似文献/References:

[1]冯宏达,高 翔.双歧三联活菌片联合蒙脱石散治疗小儿腹泻的疗效[J].医学信息,2020,33(15):144.[doi:10.3969/j.issn.1006-1959.2020.15.045]
　FENG Hong-da,GAO Xiang.Clinical Effect of Bifid Triple Viable Bacteria Tablets Combined with MontmorillonitePowder in the Treatment of Infantile Diarrhea[J].Journal of Medical Information,2020,33(06):144.[doi:10.3969/j.issn.1006-1959.2020.15.045]
[2]陶仲宾,王 洁,杨亚玲.宝乐安辅助治疗儿童反复呼吸道感染继发性腹泻的临床疗效[J].医学信息,2021,34(05):158.[doi:10.3969/j.issn.1006-1959.2021.05.045]
　TAO Zhong-bin,WANG Jie,YANG Ya-ling.The Clinical Efficacy of Baolean in Adjuvant Treatment of Diarrhea Secondary to RecurrentRespiratory Infections in Children[J].Journal of Medical Information,2021,34(06):158.[doi:10.3969/j.issn.1006-1959.2021.05.045]
[3]陈 杭.蒙脱石散联合金双歧治疗急性非感染性腹泻的临床疗效及安全性研究[J].医学信息,2022,35(24):139.[doi:10.3969/j.issn.1006-1959.2022.24.029]
　CHEN Hang.Study on the Clinical Efficacy and Safety of Montmorillonite Powder Combined with Golden Bifid in the Treatment of Acute Non-infectious Diarrhea[J].Journal of Medical Information,2022,35(06):139.[doi:10.3969/j.issn.1006-1959.2022.24.029]
[4]赵荣杰.枯草杆菌二联活菌颗粒联合蒙脱石散对小儿腹泻免疫功能及炎性状态的影响[J].医学信息,2021,34(16):169.[doi:10.3969/j.issn.1006-1959.2021.16.048]
　ZHAO Rong-jie.Effect of Combined Bacillus Subtilis and Enterococcus Faecium Granules with Multivitamines,Live Combined with Montmorillonite Powder on Immune Function and Inflammatory State of Children with Diarrhea[J].Journal of Medical Information,2021,34(06):169.[doi:10.3969/j.issn.1006-1959.2021.16.048]

更新日期/Last Update: 2019-03-15